Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
Clinical trial NCT05451043 · RECRUITING
Trial details
- NCT number
- NCT05451043
- Sponsor
- AHS Cancer Control Alberta
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-05
- Primary completion
- 2026-10-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.